mycalamide a has been researched along with Cell Transformation, Neoplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bokemeyer, C; Dyshlovoy, SA; Fedorov, SN; Honecker, F; Kalinovsky, AI; Shubina, LK; Stonik, VA | 1 |
| Higashi, K; Ogawara, H; Perry, NB; Uchino, K | 1 |
2 other study(ies) available for mycalamide a and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Mycalamide A shows cytotoxic properties and prevents EGF-induced neoplastic transformation through inhibition of nuclear factors.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Nucleus; Cell Transformation, Neoplastic; Epidermal Growth Factor; HeLa Cells; Humans; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mice; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyrans; Transcription Factor AP-1; Transcription, Genetic; Tumor Suppressor Protein p53; Urochordata | 2012 |
Change of ras-transformed NRK-cells back to normal morphology by mycalamides A and B, antitumor agents from a marine sponge.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Transformation, Neoplastic; Genes, ras; Porifera; Protein Synthesis Inhibitors; Pyrans; Tumor Cells, Cultured | 1991 |